Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineered antibodies accelerating drug discovery and development.

Z Zhu1

  • 1ImClone Systems Inc, Dept Molecular & Cellular Biology, 180 Varick St, New York, NY 10014, USA. zhenping@imclone.com.

Idrugs : the Investigational Drugs Journal
|June 3, 2005
PubMed
Summary

This meeting highlighted advancements in antibody engineering and clinical development. Key topics included novel antibody generation techniques, high-level expression systems, and promising therapeutic applications like antibody-drug conjugates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cbl-b regulates airway mucosal tolerance to aeroallergen.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2010
Same author

Reduced swimming abilities in fast-growing transgenic common carp Cyprinus carpio associated with their morphological variations.

Journal of fish biology·2010
Same author

Research and development.

Vox sanguinis·2010
Same author

Sensitization to minor antigens is a significant barrier in bone marrow transplantation and is prevented by CD154:CD40 blockade.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
Same author

Self-assembly of PEGylated peptide conjugates containing a modified amyloid beta-peptide fragment.

Langmuir : the ACS journal of surfaces and colloids·2010
Same author

Immunomodulating effects of endotoxin in mouse models of allergic asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2010

Area of Science:

  • Biotechnology and Pharmaceutical Sciences
  • Immunology and Therapeutics

Background:

  • Antibody therapeutics represent a significant area of pharmaceutical development.
  • Advances in engineering and production technologies are crucial for therapeutic efficacy.

Purpose of the Study:

  • To review recent progress in antibody engineering and clinical development.
  • To discuss challenges and innovations in antibody therapeutics.

Main Methods:

  • Review of presentations on display technologies and antibody generation.
  • Discussion of high-level antibody expression systems (mammalian cells, transgenic plants).
  • Analysis of data from ongoing clinical trials of antibody products.

Main Results:

Related Experiment Videos

  • XenoMax technology enables robust identification of high-affinity antibodies.
  • Unique approaches for identifying antibodies against tumor-specific targets were presented.
  • Transgenic plant-based antibody production shows increasing industrial interest.
  • Promising results for antibody-drug conjugates and prodrugs were reported.

    • Conclusions:

    • Innovations in antibody generation and expression are advancing therapeutic development.
    • Clinical trial data and novel therapeutic formats show significant promise.
    • Interdisciplinary collaboration is key to overcoming challenges in antibody product development.